Literature DB >> 24819833

High-frequency jet ventilation under general anesthesia facilitates CT-guided lung tumor thermal ablation compared with normal respiration under conscious analgesic sedation.

Daniel Yiu Fai Chung1, Donald Man Lap Tse1, Philip Boardman1, Fergus Vincent Gleeson1, Mark William Little1, Shaun Haig Scott2, Ewan Mark Anderson3.   

Abstract

PURPOSE: To determine whether technical difficulty of computed tomography (CT)-guided percutaneous lung tumor thermal ablations is altered with the use of high-frequency jet ventilation (HFJV) under general anesthesia (GA) compared with procedures performed with normal respiration (NR) under conscious sedation (CS).
MATERIALS AND METHODS: Thermal ablation treatment sessions performed with NR under CS or HFJV under GA with available anesthesia records and CT fluoroscopic images were retrospectively reviewed; 13 and 33 treatment sessions, respectively, were identified. One anesthesiologist determined the choice of anesthesiologic technique independently. Surrogate measures of procedure technical difficulty--time duration, number of CT fluoroscopic acquisitions, and radiation dose required for applicator placement for each tumor--were compared between anesthesiologic techniques. The anesthesiologist time and complications were also compared. Parametric and nonparametric data were compared by Student independent-samples t test and χ(2) test, respectively.
RESULTS: Patients treated with HFJV under GA had higher American Society of Anesthesiologists classifications (mean, 2.66 vs 2.23; P = .009) and smaller lung tumors (16.09 mm vs 27.38 mm; P = .001). The time duration (220.30 s vs 393.94 s; P = .008), number of CT fluoroscopic acquisitions (10.31 vs 19.13; P = .023), and radiation dose (60.22 mGy·cm vs 127.68 mGy·cm; P = .012) required for applicator placement were significantly lower in treatment sessions performed with HFJV under GA. There was no significant differences in anesthesiologist time (P = .20), rate of pneumothorax (P = .62), or number of pneumothoraces requiring active treatment (P = .19).
CONCLUSIONS: HFJV under GA appears to reduce technical difficulty of CT-guided percutaneous applicator placement for lung tumor thermal ablations, with similar complication rates compared with treatment sessions performed with NR under CS. The technique is safe and may facilitate treatment of technically challenging tumors.
Copyright © 2014 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24819833     DOI: 10.1016/j.jvir.2014.02.026

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  5 in total

1.  In-circuit high-frequency jet ventilation to reduce organ motion in a child undergoing sarcoma ablation.

Authors:  L D Elgie; K McPherson; J Yeung; L Marshall; R Windsor; S Bandula
Journal:  Anaesth Rep       Date:  2021-04-07

2.  [Expert Consensus for Thermal Ablation of Primary and Metastatic Lung Tumors 
(2017 Edition)].

Authors:  Xin Ye; Weijun Fan; Hui Wang; Junjie Wang; Shanzhi Gu; Weijian Feng; Yiping Zhuang; Baodong Liu; Xiaoguang Li; Yuliang Li; Po Yang; Xia Yang; Wuwei Yang; Junhui Chen; Rong Zhang; Zhengyu Lin; Zhiqiang Meng; Kaiwen Hu; Chen Liu; Zhongmin Peng; Yue Han; Yong Jin; Guangyan Lei; Bo Zhai; Guanghui Huang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2017-07-20

3.  High-Frequency Jet Ventilation During Cryoablation of Small Renal Tumours.

Authors:  Thea Buchan; Miles Walkden; Kathryn Jenkins; Pervez Sultan; Steve Bandula
Journal:  Cardiovasc Intervent Radiol       Date:  2018-03-07       Impact factor: 2.740

4.  Embolisation of pulmonary arteriovenous malformations using high-frequency jet ventilation: benefits of minimising respiratory motion.

Authors:  Emanuele Boatta; Roberto Luigi Cazzato; Pierre De Marini; Mathieu Canuet; Julien Garnon; Bob Heger; Thi Mai Bernmann; Nitin Ramamurthy; Christine Jahn; Marc Lopez; Afshin Gangi
Journal:  Eur Radiol Exp       Date:  2019-07-09

5.  Clinical trial protocol for TARDOX: a phase I study to investigate the feasibility of targeted release of lyso-thermosensitive liposomal doxorubicin (ThermoDox®) using focused ultrasound in patients with liver tumours.

Authors:  Paul C Lyon; Lucy F Griffiths; Jenni Lee; Daniel Chung; Robert Carlisle; Feng Wu; Mark R Middleton; Fergus V Gleeson; Constantin C Coussios
Journal:  J Ther Ultrasound       Date:  2017-11-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.